Article: SPIRIVA SIGNIFICANTLY IMPROVES LUNG FUNCTION IN PATIENTS WITH MILD COPD.

(Full text of statement. Contact details below.)

MUNICH, Sept. 5 /PRNewswire-AsiaNet/ --

For Non-US Media Only

- First Prospective Study to Investigate the Effect of SPIRIVA(R) in Early Stage COPD, an Under-Diagnosed Condition Affecting Overall one in ten Adults Globally

Patients with mild(x) chronic obstructive pulmonary disease (COPD) treated with SPIRIVA(R) (tiotropium) experienced significantly improved lung function compared with patients receiving placebo, according to the results of a study presented today at the annual meeting of the European Respiratory Society (ERS) congress.(1) This is the first prospective study to focus ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!